- Home
- FOA vs ARCT Comparison
FOA vs ARCT Comparison
Compare FOA & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- ARCT
- Stock Information
- Founded
- FOA 2013
- ARCT 2013
- Country
- FOA United States
- ARCT United States
- Employees
- FOA N/A
- ARCT N/A
- Industry
- FOA Finance Companies
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- FOA Finance
- ARCT Health Care
- Exchange
- FOA Nasdaq
- ARCT Nasdaq
- Market Cap
- FOA 272.8M
- ARCT 320.8M
- IPO Year
- FOA N/A
- ARCT N/A
- Fundamental
- Price
- FOA $21.96
- ARCT $20.88
- Analyst Decision
- FOA Buy
- ARCT Strong Buy
- Analyst Count
- FOA 2
- ARCT 9
- Target Price
- FOA $27.50
- ARCT $50.88
- AVG Volume (30 Days)
- FOA 149.6K
- ARCT 829.2K
- Earning Date
- FOA 11-05-2025
- ARCT 11-06-2025
- Dividend Yield
- FOA N/A
- ARCT N/A
- EPS Growth
- FOA N/A
- ARCT N/A
- EPS
- FOA 7.10
- ARCT N/A
- Revenue
- FOA $527,520,999.00
- ARCT $122,122,000.00
- Revenue This Year
- FOA $21.21
- ARCT N/A
- Revenue Next Year
- FOA $10.95
- ARCT $28.92
- P/E Ratio
- FOA $3.10
- ARCT N/A
- Revenue Growth
- FOA 46.94
- ARCT N/A
- 52 Week Low
- FOA $10.00
- ARCT $8.04
- 52 Week High
- FOA $32.40
- ARCT $24.13
- Technical
- Relative Strength Index (RSI)
- FOA 33.97
- ARCT 56.07
- Support Level
- FOA $21.25
- ARCT $20.08
- Resistance Level
- FOA $22.83
- ARCT $23.60
- Average True Range (ATR)
- FOA 1.04
- ARCT 1.71
- MACD
- FOA -0.19
- ARCT -0.01
- Stochastic Oscillator
- FOA 13.27
- ARCT 48.61
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.